✦ LIBER ✦

B3.2 The role of the viral genotype in hepatitis C virus (HCV) and human deficiency virus-1 (HIV-1) co-infected patients

Book ID: 119564042
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 213 KB
Volume: 26
Category: Article
ISSN: 0924-8579
DOI: 10.1016/s0924-8579(05)80244-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Genotype 2 and Genotype 3 H

Treatment of Genotype 2 and Genotype 3 Hepatitis C Virus (HCV) Infection in Human Immunodeficiency Virus Positive Patients

✍ Brown, Kristen; LaBrie, Martin; Coffin, Carla S. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 188 KB

385 Pharmacodynamics and pharmacokinetic

385 Pharmacodynamics and pharmacokinetics of hepatitis C virus (HCV) and pegylated interferon-alfa2B in human immunodeficiency virus (HIV)/HCV co-infected patients

✍ Preeti Golia; Kimberly Powers; Gary Dorante; Susanna Cunningham-Rundles; Ruy Rib 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Hepatitis C (HCV) genotype and viral tit

Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection

✍ Picchio, Gastón R.; Nakatsuno, Mónica; Boggiano, César; Sabbe, Rebecca; Corti, M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

Hepatits C (HCV) infection is frequent among hemophilic patients treated with non-inactivated factor-concentrates. Both HCV genotype and viral load have been suggested to be important prognostic markers of disease progression and treatment outcome. In addition, co-infection with the human immunodefi

Occult hepatitis B virus infection in th

Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: Clinically relevant or a diagnostic problem?

✍ M. Rodríguez-Torres; J. Gonzalez-Garcia; N. Bräu; R. Solá; S. Moreno; J. Rockstr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

## Abstract The clinical relevance of occult hepatitis B virus (HBV) infection, defined as detectable HBV DNA serum/liver, in the absence of hepatitis B surface antigen (HBsAg), is unclear. We determined the prevalence of serum occult HBV infection in HIV/HCV co‐infected patients enrolled in APRICO

The risk of adefovir monotherapy in huma

The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients

✍ Luc B.S. Gelinck; Eric C.J. Claas; Frank P. Kroon 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Prevalence of antibody to hepatitis C vi

Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice seroco cohort)

✍ J. F. Quaranta; S. R. Delaney; S. Alleman; J. P. Cassuto; P. Dellamonica; J. P. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

## Abstract The prevalence of antibody to hepatitis C virus (HCV) in a cohort of 272 HIV‐infected patients was assessed by means of 4 anti‐HCV assays: a 1st generation and a neutralization test, a 2nd generation test, and a confirmatory test, the dot‐blot Matrix HCV™ immunoassay. The cohort include